Infliximab (Remicade)
Merck Sharp & Dohme
Description
Remicade 100mg (infliximab) powder for concentrate for solution for infusion. Infliximab is a chimeric human-murine IgG1 monoclonal antibody produced in murine hybridoma cells by recombinant DNA technology. After reconstitution each ml contains 10mg of infliximab.
Indications
Infliximab, in combination with methotrexate, is indicated for the reduction of signs and symptoms as well as the improvement in physical function in adult patients with active disease when the response to disease-modifying antirheumatic drugs (DMARDs), including methotrexate, has been inadequate. Also, in adult patients with severe, active and progressive disease not previously treated with methotrexate or other DMARDs.
Price
100mg, price on application
More on: Systemic psoriasis treatments